Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, June 08, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the William Blair 36th Annual Growth Stock Conference on Thursday, June 16, 2016, at 8:40 a.m. Central Time in Chicago. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Invuity® Invuity, In...Read More
San Francisco, CA, May 13, 2016 – Invuity Inc. has been awarded the Innovative Technology Award from Vizient, Inc., the largest member-owned health care company in the United States. The award was presented at the 2016 Vizient Supplier Summit, held in Las Vegas. The sole Innovative Technology Award recognizes Invuity’s positive impact on surgical precision, efficiency, safety and overall patient care in the operating room. Vizient members who have adopted Invuity’s Intelligent Photonics™ technology are drawn to its high quality intracavity illumination and visualization and thermally cool safety attributes that enable open, minimal access and Hidden Scar™ surgical procedures.“We a...Read More
SAN FRANCISCO, May 05, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today reported financial results for the first quarter ended March 31, 2016. Q1 2016 Highlights Revenue grew 44% to $6.4 million compared to revenue of $4.4 million in the 2015 first quarter. Gross margin improved to 67% compared to 61% in the 2015 first quarter. Approximately 545 hospitals purchased Invuity devices in the first quarter of 2016, up from 410 hospitals in the first quarter of 2015. Approximately 162,000 procedures have been performed using Invuity devices. "We are pleased with our first quarter operational and financial results,” said President...Read More
“Invuity’s Saber handheld illuminator with Frazier suction enables me to more efficiently achieve rapid hemostasis during cervical and lumbar spine surgery. I’m able to direct its light precisely where it is needed to quickly locate and control bleeders especially in far lateral recesses and deep surgical cavities. Since using the Eigr Saber I have seen a significant decrease in blood loss due to its superior illumination within the incision.”
Formerly Chief, Division of Spinal Surgery
Brigham and Women's Hospital
Assistant Professor of Surgery, Harvard Medical School
“It is not often you see new technology or medical devices and know how much you will like it and the impact it will make before you even use it! That is exactly what happened with Invuity’s Eikon Illuminated Retractor System.”
“The Invuity illuminated retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
Past President, American Society of Breast Surgeons
Chief of Breast Surgery
Professor of Surgery, Weill Cornell Medical College
Edwin C. Weiskopf Professor of Surgical Oncology New York, NY